Latest news
NADairX debuts inhalable NAD+ delivery platform
NADairX is a new pulmonary delivery platform designed to provide the user with consistent exposure to NAD+.
A natural molecule found in every living cell, NAD+ (nicotinamide adenine dinucleotide) supports cellular energy production and promotes DNA repair.
The new device delivers 60 mg of inhalable NAD+ directly to the lungs, allowing rapid absorption into the bloodstream while bypassing digestive barriers that can limit oral supplementation. Each capsule contains a precisely measured dose of NAD+, supporting consistent and repeatable delivery.
NADairX was co-founded by Erin Lee, wellness entrepreneur and founder of the Touchless Wellness Association, and Iain De Havilland, longevity researcher and founder of its supporting platform, NADclinic.
The platform offers a way to help democratise access to NAD+ therapies.
The initial rollout will focus on B2B partners, including longevity clinics, wellness operators, recovery centres and fitness facilities.
Erin Lee, co-founder and CEO of NADairX, said: “Our goal was to explore whether pulmonary delivery could offer a more accessible and scalable way for people to engage with NAD+ therapies.”
Iain De Havilland, founder of NADclinic, says: “As interest in NAD+ therapies continues to grow, it’s important that we explore delivery methods that are practical, scalable and biologically credible.”
With our team of medical professionals specialising in nutrition, neurology and complementary therapies, we aim to improve your psychological health, along with your physical health and performance. We do this by harnessing the unique power of essential and life-changing NAD+, a molecule that helps our cells produce energy. It can mitigate the debilitating effects of ageing, illness and chronic pain.
The NADclinic brand is trademarked internationally including the US and recognised as a leader in NAD product innovation. Currently, NADclinic cooperates with 30+ leading clinics across the globe, with their trademark protocol menu being uniformly adopted by all preferred partners.
The NADclinic brand is now active in 40 countries across 5 continents with NADclinic best-in-class products and services, now available extensively worldwide, including the UK, Europe, the United States, UAE, South Africa, Japan, China, and throughout the APAC region.
Latest news
Work is underway in Madrid on one of Europe’s most significant multi-functional complexes,














































